That is very important, because the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective. To put it simply, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (jeff brown biotech picks). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. This was a breakthrough practically no one saw. However it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment opportunities in this area, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (black sea). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe significantly prior to going higher - jeff brown biotech pick. I've been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mainly educating readers. However that's not the huge concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown biotech picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many great personal business on the edge of hitting the general public markets And I've been working on a brand-new method for you to invest even before these business go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Diary. Routine Diary readers know that tech isn't our typical beat (melania trump). And when it concerns tech investing, we leave it to the experts. The good news is, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we know (second wave). In reality, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing exponential development and developing incredible chances for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown predictions 2021. But regardless of what many readers might think, this is a trend that's just getting going. Even though the COVID-19 pandemic disrupted supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions). Losing 2 months of production and sales actually impacts how numerous 5G gadgets are sold in the calendar year. When you consider all of that, offering 250 million units is amazing. More significantly, the hold-ups triggered by the pandemic produced a lot of suppressed demand. And that need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown prediction. And that's not my only 5G forecast When I have actually talked about 5G in the past, I have actually described its 3 different stages.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Stage Three, 5G services start to be used (bleeding edge). That's when we begin to see applications operating on 5G networks. Think about things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summertime. This starts something of a virtuous cycle: The majority of people do not actually care about the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open a suite of incredible applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities going forward will be massive. Stepping far from 5G, the next important innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a similar idea however with our genetic code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well understood. And during that time, there were truly only 3 business running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This whole market is successfully a greenfield chance.
There's space for many companies to exist in this area. united states. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software application can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is necessary since the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been an experimental process. And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced using this technology. This was among those breakthroughs that practically nobody discovered. But it's going to have profound ramifications for curing disease. And, of course, there will be a lot of investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly significantly prior to going higher. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - last week. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. united arab emirates. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date since February 2021, but we might not independently verify this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like ability to select winning technology stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding perspective on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his best picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully anticipated a few of the greatest economic events of the previous 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, but Jeff Brown's precise forecasts have actually made him legions of dedicated fans. That says a lot about his ability. The Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research offers a number of research services with a large range of expertises - jeff brown tech stock 2021.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - jeff brown biotech stock. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the very best investment research has not been readily available to individual financiers. It has actually been normally booked for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown predictions for 2021. The objective of Brownstone Research is to make that kind of exclusive research study readily available to any financiers seeking to gain an edge in the marketplaces. The goal is basic to deliver unique and lucrative investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise works as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout most of America. If you understand even a little bit about the market, you know that he has a reputation as a King Midas of sorts. diplomatic relations. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown thinks S.A.V. brownstone research. might be "the greatest trend of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 cutting-edge technologies: expert system and electric cars. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automotive market's Holy Grail. As you understand, electrical vehicles and self-driving vehicle stocks have actually been substantial this year, however the Wall Street maker has actually been big on buzz without much tangible result. In spite of a drastic boost in competition over the past few years, Brown still thinks Musk has the best possibility of putting it all together.
tech might be the magic string that connects everything together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transportation. Basically, this technology would permit you to rent your cars and truck as an autonomous, self-driving taxi when you're not using it. You simply leave the automobile and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the profits. It sounds crazy, however it might be closed than you believe.